Heterogeneity and Risk-of-Biases are No Longer the Issues to Conclude the Effectiveness of Baricitinib in Reducing COVID-19 Related Mortality: A Systematic Review and Meta-Analysis of Eight Randomised Controlled Trials

Sivananthan Manoharan, Lee Ying Ying
doi: https://doi.org/10.1101/2022.11.07.22282055

Article usage

Article usage: November 2022 to November 2024

AbstractFullPdf
Nov 20226331165
Dec 202280021
Jan 20233903
Feb 20232017
Mar 20234513
Apr 20232412
May 20232318
Jun 20231144
Jul 2023912
Aug 202319108
Sep 20231044
Oct 2023940
Nov 20231024
Dec 20231701
Jan 2024712
Feb 20241004
Mar 2024303
Apr 2024801
May 2024804
Jun 20241006
Jul 2024405
Aug 20241605
Sep 20242356
Oct 2024723
Nov 2024100
Back to top
Posted November 11, 2022.
Download PDF
Data/Code
Email
Heterogeneity and Risk-of-Biases are No Longer the Issues to Conclude the Effectiveness of Baricitinib in Reducing COVID-19 Related Mortality: A Systematic Review and Meta-Analysis of Eight Randomised Controlled Trials
Sivananthan Manoharan, Lee Ying Ying
medRxiv 2022.11.07.22282055; doi: https://doi.org/10.1101/2022.11.07.22282055
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area